Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency

Autosomal recessive mutations in the thymidine kinase 2 gene (TK2) cause mitochondrial DNA depletion, multiple deletions, or both due to loss of TK2 enzyme activity and ensuing unbalanced deoxynucleotide triphosphate (dNTP) pools. To bypass Tk2 deficiency, we administered deoxycytidine and deoxythymidine monophosphates (dCMP+dTMP) to the Tk2 H126N (Tk2−/−) knock‐in mouse model from postnatal day 4, when mutant mice are phenotypically normal, but biochemically affected. Assessment of 13‐day‐old Tk2−/− mice treated with dCMP+dTMP 200 mg/kg/day each (Tk2−/−200dCMP/dTMP) demonstrated that in mutant animals, the compounds raise dTTP concentrations, increase levels of mtDNA, ameliorate defects of mitochondrial respiratory chain enzymes, and significantly prolong their lifespan (34 days with treatment versus 13 days untreated). A second trial of dCMP+dTMP each at 400 mg/kg/day showed even greater phenotypic and biochemical improvements. In conclusion, dCMP/dTMP supplementation is the first effective pharmacologic treatment for Tk2 deficiency.

[1]  V. Bianchi,et al.  The pyrimidine nucleotide carrier PNC1 and mitochondrial trafficking of thymidine phosphates in cultured human cells. , 2012, Experimental cell research.

[2]  W. Copeland.  Defects in mitochondrial DNA replication and human disease , 2010, Critical reviews in biochemistry and molecular biology.

[3]  M. Hirano,et al.  Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity. , 2012, Methods in molecular biology.

[4]  M. Hirano,et al.  Measurement of mitochondrial dNTP pools. , 2012, Methods in molecular biology.

[5]  A. Paetau,et al.  Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. , 2012, Human molecular genetics.

[6]  M. Hirano,et al.  Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. , 2011, Brain : a journal of neurology.

[7]  J. Schellens,et al.  Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites? , 2011, Fundamental & clinical pharmacology.

[8]  H. Akman,et al.  Onset and organ specificity of Tk2 deficiency depends on Tk1 down-regulation and transcriptional compensation. , 2011, Human molecular genetics.

[9]  P. Reichard,et al.  Quantitation of cellular deoxynucleoside triphosphates , 2009, Nucleic acids research.

[10]  P. Chinnery,et al.  In vitro supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes. , 2009, Human molecular genetics.

[11]  I. Nishino,et al.  Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. , 2009, Human molecular genetics.

[12]  M. Zeviani,et al.  Mitochondrial diseases: a cross-talk between mitochondrial and nuclear genomes. , 2009, Advances in experimental medicine and biology.

[13]  A. Paetau,et al.  Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. , 2008, Brain : a journal of neurology.

[14]  W. Dauer,et al.  Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance. , 2008, Human molecular genetics.

[15]  A. Karlsson,et al.  Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. , 2008, Human molecular genetics.

[16]  A. Munnich,et al.  Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion , 2007, Annals of neurology.

[17]  Morten Duno,et al.  Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. , 2007, American journal of human genetics.

[18]  Yusuke Nakamura,et al.  Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion , 2007, Nature Genetics.

[19]  P. Bernardi,et al.  Mitochondrial deoxynucleotide pool sizes in mouse liver and evidence for a transport mechanism for thymidine monophosphate , 2006, Proceedings of the National Academy of Sciences.

[20]  S. Dimauro,et al.  Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE , 2006, Neurology.

[21]  Sarah Calvo,et al.  MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion , 2006, Nature Genetics.

[22]  N. Bresolin,et al.  New mutations in TK2 gene associated with mitochondrial DNA depletion. , 2006, Pediatric neurology.

[23]  Maria Bitner-Glindzicz,et al.  Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. , 2005, American journal of human genetics.

[24]  E. Bertini,et al.  Mitochondrial DNA Depletion , 2005 .

[25]  R. Naviaux,et al.  POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion , 2004, Annals of neurology.

[26]  M. Hirano,et al.  Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A Disease of Two Genomes , 2004, The neurologist.

[27]  H. Mandel,et al.  Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency. , 2003, Biochemical and biophysical research communications.

[28]  M. Hirano,et al.  Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. , 2003, Biochemical and biophysical research communications.

[29]  I. Nishino,et al.  Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. , 2001, Seminars in cell & developmental biology.

[30]  H. Mandel,et al.  Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy , 2001, Nature Genetics.

[31]  H. Mandel,et al.  The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA , 2001, Nature Genetics.

[32]  I. Nishino,et al.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.

[33]  R. Bicknell,et al.  Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. , 1998, The Biochemical journal.

[34]  V. Heinemann,et al.  Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine. , 1989, Biochemical pharmacology.

[35]  S. Dimauro,et al.  Cytochrome c oxidase deficiency in leigh syndrome , 1987, Annals of neurology.

[36]  S. Kit.  Thymidine kinase. , 1985, Microbiological sciences.